A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD

Pfizer

Status and phase: Completed; Phase 2; Phase 1

Conditions: Pulmonary Disease, Chronic Obstructive

Treatments: Drug: UK-369,003

Study type: Interventional

Funder types: Industry

Identifiers

NCT00163098

A3711028

Details and patient eligibility

About

A randomised, controlled study investigating the effect of UK-369,003 on exercise tolerance in patients with COPD

Sex: All

Ages: 35 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• GOLD criteria 2 to 4
• 10 pack year history of smoking

Exclusion criteria

• Women of child bearing potential

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind